Tissue‐ and cell‐expression of druggable host proteins provide insights into repurposing drugs for COVID‐19

• Päätekijät: Jiapeng Li (Tekijä), Yanling Xue (Tekijä), Xinwen Wang (Tekijä), Logan S. Smith (Tekijä), Bing He (Tekijä), Shuhan Liu (Tekijä), Hao‐Jie Zhu (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Wiley, 2022-12-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Several human host proteins play important roles in the lifecycle of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Many drugs targeting these host proteins have been investigated as potential therapeutics for coronavirus disease 2019 (COVID‐19). The tissue‐specific expressio...